Eli Lilly Launches Flat Pricing For Zepbound, Capping Monthly Cost At $499

Eli Lilly expands Zepbound access with flat-rate pricing and new vial options, supporting wider obesity treatment access without insurance barriers.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *